Bayer Aktiengesellschaft (LON:0P6S)

London flag London · Delayed Price · Currency is GBP · Price in EUR
23.05
+0.60 (2.69%)
At close: Apr 25, 2025
-16.18%
Market Cap 19.25B
Revenue (ttm) 38.54B
Net Income (ttm) -2.11B
Shares Out n/a
EPS (ttm) -2.15
PE Ratio n/a
Forward PE n/a
Dividend 0.09 (0.41%)
Ex-Dividend Date Apr 28, 2025
Volume 1,394,811
Average Volume 2,057,155
Open 22.59
Previous Close 22.45
Day's Range 22.42 - 23.13
52-Week Range 15.25 - 29.88
Beta 1.01
RSI 58.90
Earnings Date May 13, 2025

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin... [Read more]

Industry Chemicals and Allied Products
Founded 1863
Employees 90,587
Stock Exchange London Stock Exchange
Ticker Symbol 0P6S
Full Company Profile

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.

Financial numbers in EUR Financial Statements

News

There is no news available yet.